Clinical Trials · NCT01368263
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
- Phase
- Phase 2
- Recruitment status
- Terminated
- Sponsor
- Washington University School of Medicine
- Enrollment
- 8
- Start date
- Sep 2011
- Locations
- 1 site, United States
- Primary endpoint
- Pathologic Complete Response (CR) Rate